세계의 일회용 펌프 시장 성장 기회

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

신형 코로나바이러스(COVID-19) 대유행에 의해 제약 업계에서는 생산 규모가 빠르게 확대되었습니다. FDA의 생물제제 승인 건수 증가는 북미/아시아의 생물제제 생산을 한층 더 가속시켰습니다. 향후 5-7년간 바이오의약품 붐이 예상되기 때문에 펌프, 바이오리액터, 믹서, 튜브, 커넥터, 소모품 등의 일회용 솔루션 수요가 크게 증가할 것으로 예상됩니다. 일회용 펌프(SUP)나 기타 일회용 기술(SUT)은 비용과 시간 효율화 효과로 인해 제약 업계용을 중심으로 낙관적인 성장 전망을 나타내고 있습니다.

세계의 일회용 펌프(SUP) 및 일회용 기술(SUT) 시장을 분석했으며, 시장의 기본 구조, 주요 시장 성장 촉진요인 및 억제요인, 시장 규모 동향 전망(향후 5년간), 부문별·지역별·업종별 상세 동향, 주요 기업 개요와 경쟁력, 향후 성장 기회와 과제 등에 대해 전해드립니다.

목차

전략적 과제

일회용 펌프(SUP) 및 일회용 기술(SUT) : 성장 기회 분석

• 세계의 SUP : 분석 범위
• 시장 구분
• SUT : 주요 성장 지표
• SUP : 주요 성장 지표
• SUT : 성장 촉진요인
• SUT : 성장 억제요인
• 예측의 전제조건
• SUT : 매출 예측, SUT
• SUT : 수익률, 부문별
• SUP : 매출 예측, SUT
• SUP : 수익률, 부문별
• SUP : 수익률, 업종별
• 경쟁 구도
• SUT : 시장 진출 기업 리스트, 부문별

일회용 기술(SUT) : 시장 개요

• SUT : 시장 발전
• SS와 SUT
• 업스트림(Upstream) 공정 바이오프로세싱 제조 비용
• SUT : 인수합병(M&A)
• 기업 개요 : Levitronix
• 기업 개요 : PumpCell

일회용 펌프(SUP) 및 일회용 기술(SUT) : 고객의 견해

• SUT : 밸류체인 전체에서의 채택
• SUT : 바이오의약품 제조에서의 사용
• SUT 채택 확대의 장애요인
• 고객으로부터의 피드백 : 인터뷰(발췌)

성장 기회 : 일회용 기술(SUT)

• 성장 기회(1) : SUT 채택 추진을 위한 세포·유전자 치료 제조에서의 기술 혁신
• 성장 기회(2) : 제조업에서의 SUT 수요를 자극하기 위한 차세대 생물제제의 표준화
• 성장 기회(3) : SUP 채택 추진을 위한 레이저 활성화 SU-마이크로 펌프의 비용 효율성
• 도표
• 면책사항

Disruptive Technologies and Innovative Business Models to Unleash Cost-efficient, Safe, and Sustainable Single-use Solutions

The COVID-19 pandemic led to the rapid scaling up of production activities in the pharmaceutical industry. An increase in the number of FDA approvals in biologics has further accelerated biopharmaceutical production, particularly in North America and Asia. With a boom in biopharmaceuticals anticipated in the next 5 to 7 years, the demand for single-use solutions, such as pumps, bioreactors, mixers, tubing, connectors, consumables, and other instrumentation is expected to increase significantly. The cost and time efficiencies achieved with single-use pumps and other single-use technologies offer an optimistic growth outlook, particularly for the pharmaceutical industry. The demand for contract manufacturing organizations (CMOs) is becoming more pronounced and is expected to further accelerate the usage of the single-use solution.

In this study, Frost & Sullivan has identified, analyzed, and evaluated the existing and upcoming trends impacting the global single-use pumps and technologies market. The study offers insights into the growth prospects for single-use pump manufacturers for the next 5 years. It also discusses the product, market, and technology growth opportunities impacting the industry's future. The regions covered include North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa.

The study provides an overview of the growth drivers and restraints concerning single-use pumps and technologies. It also provides the revenue opportunity for the total market and breakdowns by various product segments, industry verticals, and regions. The study also offers a short analysis of the competitive mapping to understand the existing market landscape and opportunities available for OEMs. Additionally, a brief snapshot of the voice-of-the-customer based on interviews conducted has been presented in this research. The intent is to highlight the current pulse of the market towards single-use pumps and technology. Three major growth opportunities are likely to influence single-use manufacturers' market positions in the future. They are:

• Technology breakthrough in cell and gene therapy manufacturing to boost the adoption of single-use technology

• Standardization of next-generation biologics to stimulate the demand for single-use technology in manufacturing

• Cost-efficiency of the laser-activated single-use micropump to promote the adoption of single-use pumps

For the study, a specific methodology comprising discussions with the senior management in single-use pump and technology companies, supported by secondary research, has been followed.

Table of Contents

Strategic Imperatives

• Why Is It Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on Single-use Pumps (SUPs) and Single-use Technology (SUT)
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis, SUPs and SUT

• Global SUPs, Scope of Analysis
• Market Segmentation
• Key Growth Metrics for SUT
• Key Growth Metrics for SUPs
• Growth Drivers for SUT
• Growth Restraints for SUT
• Growth Drivers and Restraints for SUPs
• SUPs, Growth Drivers Explained
• SUPs, Growth Drivers Explained (continued)
• SUPs, Growth Restraints Explained
• SUPs, Growth Restraints Explained (continued)
• Forecast Assumptions
• Revenue Forecast, SUT
• Percent Revenue by Segment, SUT
• Revenue Forecast Analysis, SUT
• Revenue Forecast, SUPs
• Revenue Forecast Analysis, SUPs
• Percent Revenue by Region, SUPs
• Revenue Forecast Analysis by Region, SUPs
• Percent Revenue by Industry Vertical, SUPs
• Revenue Forecast Analysis by Industry Vertical, SUPs
• Competitive Landscape
• List of Market Participants by Segment, SUT
• List of Market Participants by Segment, SUT (continued)
• List of Market Participants by Segment, SUT (continued)

Market Overview, SUT

• SUT, Market Evolution
• SS Versus SUT
• Cost of Manufacturing in Upstream Bioprocessing
• Mergers and Acquisitions, SUT
• Mergers and Acquisitions, SUT (continued)
• Mergers and Acquisitions, SUT (continued)
• Company Profile-Levitronix
• Company Profile-PumpCell

Voice of Customer, SUPs and SUT

• SUT, Adoption across Value Chain
• Usage of SUT in Biopharma Manufacturing
• Roadblocks for Increased Adoption of SUT
• Customer Feedback, Selected Quotes from Interviews

Growth Opportunity Universe, SUPs and SUT

• Growth Opportunity 1-Technology Breakthrough in Cell and Gene Therapy Manufacturing to Boost Adoption of SUT
• Growth Opportunity 1-Technology Breakthrough in Cell and Gene Therapy Manufacturing to Boost Adoption of SUT (continued)
• Growth Opportunity 2-Standardization of Next-generation Biologics to Stimulate Demand for SUT in Manufacturing
• Growth Opportunity 2-Standardization of Next-generation Biologics to Stimulate Demand for SUT in Manufacturing (continued)
• Growth Opportunity 3-Cost-efficiency of Laser-activated SU-micropump to Promote Adoption of SUP
• Growth Opportunity 3-Cost-efficiency of Laser-activated SU-micropump to Promote Adoption of SUP (continued)
• List of Exhibits
• List of Exhibits (continued)
• Legal Disclaimer